Endoscopic pyloromyotomy in minimally invasive esophagectomy: a novel approach.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
04 2022
Historique:
received: 23 02 2021
accepted: 17 04 2021
pubmed: 6 5 2021
medline: 21 4 2022
entrez: 5 5 2021
Statut: ppublish

Résumé

Pyloric drainage procedures, namely pyloromyotomy or pyloroplasty, have long been considered an integral aspect of esophagectomy. However, the requirement of pyloric drainage in the era of minimally invasive esophagectomy (MIE) has been brought into question. This is in part because of the technical challenges of performing the pyloric drainage laparoscopically, leading many surgical teams to explore other options or to abandon this procedure entirely. We have developed a novel, technically facile, endoscopic approach to pyloromyotomy, and sought to assess the efficacy of this new approach compared to the standard surgical pyloromyotomy. Patients who underwent MIE for cancer from 01/2010 to 12/2019 were identified from a prospectively maintained institutional database and were divided into two groups according to the pyloric drainage procedure: endoscopic or surgical pyloric drainage. 30-day outcomes (complications, length of stay, readmissions) and pyloric drainage-related outcomes [conduit distension/width, nasogastric tube (NGT) duration and re-insertion, gastric stasis] were compared between groups. 94 patients were identified of these 52 patients underwent endoscopic PM and 42 patients underwent surgical PM. The groups were similar with respect to age, gender and comorbidities. There were more Ivor-Lewis esophagectomies in the endoscopic PM group than the surgical PM group [45 (86%), 15 (36%) p < 0.001]. There was no significant difference in the rate of complications and readmissions. Gastric stasis requiring NGT re-insertion was rare in the endoscopic PM group and did not differ significantly from the surgical PM group (1.9-4.7% p = 0.58). Endoscopic pyloromyotomy using a novel approach is a safe, quick and reproducible technique with comparable results to a surgical PM in the setting of MIE.

Sections du résumé

BACKGROUND
Pyloric drainage procedures, namely pyloromyotomy or pyloroplasty, have long been considered an integral aspect of esophagectomy. However, the requirement of pyloric drainage in the era of minimally invasive esophagectomy (MIE) has been brought into question. This is in part because of the technical challenges of performing the pyloric drainage laparoscopically, leading many surgical teams to explore other options or to abandon this procedure entirely. We have developed a novel, technically facile, endoscopic approach to pyloromyotomy, and sought to assess the efficacy of this new approach compared to the standard surgical pyloromyotomy.
METHODS
Patients who underwent MIE for cancer from 01/2010 to 12/2019 were identified from a prospectively maintained institutional database and were divided into two groups according to the pyloric drainage procedure: endoscopic or surgical pyloric drainage. 30-day outcomes (complications, length of stay, readmissions) and pyloric drainage-related outcomes [conduit distension/width, nasogastric tube (NGT) duration and re-insertion, gastric stasis] were compared between groups.
RESULTS
94 patients were identified of these 52 patients underwent endoscopic PM and 42 patients underwent surgical PM. The groups were similar with respect to age, gender and comorbidities. There were more Ivor-Lewis esophagectomies in the endoscopic PM group than the surgical PM group [45 (86%), 15 (36%) p < 0.001]. There was no significant difference in the rate of complications and readmissions. Gastric stasis requiring NGT re-insertion was rare in the endoscopic PM group and did not differ significantly from the surgical PM group (1.9-4.7% p = 0.58).
CONCLUSIONS
Endoscopic pyloromyotomy using a novel approach is a safe, quick and reproducible technique with comparable results to a surgical PM in the setting of MIE.

Identifiants

pubmed: 33948713
doi: 10.1007/s00464-021-08511-0
pii: 10.1007/s00464-021-08511-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2341-2348

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Low DE, Allum W, De Manzoni G, Ferri L, Immanuel A, Kuppusamy M, Law S, Lindblad M, Maynard N, Neal J, Pramesh CS, Scott M, Mark Smithers B, Addor V, Ljungqvist O (2019) Guidelines for perioperative care in esophagectomy: Enhanced Recovery After Surgery (ERAS(®)) Society recommendations. World J Surg 43:299–330
doi: 10.1007/s00268-018-4786-4
Banki F, Mason RJ, DeMeester SR, Hagen JA, Balaji NS, Crookes PF, Bremner CG, Peters JH, DeMeester TR (2002) Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 236:324–335 (discussion 335–326)
doi: 10.1097/00000658-200209000-00009
Lee HS, Kim MS, Lee JM, Kim SK, Kang KW, Zo JI (2005) Intrathoracic gastric emptying of solid food after esophagectomy for esophageal cancer. Ann Thorac Surg 80:443–447
doi: 10.1016/j.athoracsur.2005.02.049
Collard JM, Romagnoli R, Otte JB, Kestens PJ (1998) The denervated stomach as an esophageal substitute is a contractile organ. Ann Surg 227:33–39
doi: 10.1097/00000658-199801000-00005
Akkerman RD, Haverkamp L, van Hillegersberg R, Ruurda JP (2014) Surgical techniques to prevent delayed gastric emptying after esophagectomy with gastric interposition: a systematic review. Ann Thorac Surg 98:1512–1519
doi: 10.1016/j.athoracsur.2014.06.057
Fok M, Cheng SW, Wong J (1991) Pyloroplasty versus no drainage in gastric replacement of the esophagus. Am J Surg 162:447–452
doi: 10.1016/0002-9610(91)90258-F
Law S, Cheung MC, Fok M, Chu KM, Wong J (1997) Pyloroplasty and pyloromyotomy in gastric replacement of the esophagus after esophagectomy: a randomized controlled trial. J Am Coll Surg 184:630–636
pubmed: 9179120
Zhang M, Wu QC, Li Q, Jiang YJ, Zhang C, Chen D (2013) Comparison of the health-related quality of life in patients with narrow gastric tube and whole stomach reconstruction after oncologic esophagectomy: a prospective randomized study. Scand J Surg 102:77–82
doi: 10.1177/1457496913482234
Burt M, Scott A, Williard WC, Pommier R, Yeh S, Bains MS, Turnbull AD, Fortner JG, McCormack PM, Ginsberg RJ (1996) Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: a randomized clinical trial. J Thorac Cardiovasc Surg 111:649–654
doi: 10.1016/S0022-5223(96)70318-5
Kent MS, Pennathur A, Fabian T, McKelvey A, Schuchert MJ, Luketich JD, Landreneau RJ (2007) A pilot study of botulinum toxin injection for the treatment of delayed gastric emptying following esophagectomy. Surg Endosc 21:754–757
doi: 10.1007/s00464-007-9225-9
Nobel T, Tan KS, Barbetta A, Adusumilli P, Bains M, Bott M, Jones D, Molena D (2019) Does pyloric drainage have a role in the era of minimally invasive esophagectomy? Surg Endosc 33:3218–3227
doi: 10.1007/s00464-018-06607-8
Eldaif SM, Lee R, Adams KN, Kilgo PD, Gruszynski MA, Force SD, Pickens A, Fernandez FG, Luu TD, Miller DL (2014) Intrapyloric botulinum injection increases postoperative esophagectomy complications. Ann Thorac Surg 97:1959–1964 (discussion 1964-1955)
doi: 10.1016/j.athoracsur.2013.11.026
Swanson EW, Swanson SJ, Swanson RS (2012) Endoscopic pyloric balloon dilatation obviates the need for pyloroplasty at esophagectomy. Surg Endosc 26:2023–2028
doi: 10.1007/s00464-012-2151-5
Hadzijusufovic E, Tagkalos E, Neumann H, Babic B, Heinrich S, Lang H, Grimminger PP (2019) Preoperative endoscopic pyloric balloon dilatation decreases the rate of delayed gastric emptying after Ivor-Lewis esophagectomy. Dis Esophagus 32
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
doi: 10.1016/0021-9681(87)90171-8
Rice TW, Patil DT, Blackstone EH (2017) 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 6:119–130
doi: 10.21037/acs.2017.03.14
Li C, Ferri LE, Mulder DS, Ncuti A, Neville A, Lee L, Kaneva P, Watson D, Vassiliou M, Carli F, Feldman LS (2012) An enhanced recovery pathway decreases duration of stay after esophagectomy. Surgery 152:606–614 (discussion 614–606)
doi: 10.1016/j.surg.2012.07.021
Cools-Lartigue J, Andalib A, Abo-Alsaud A, Gowing S, Nguyen M, Mulder D, Ferri L (2014) Routine contrast esophagram has minimal impact on the postoperative management of patients undergoing esophagectomy for esophageal cancer. Ann Surg Oncol 21:2573–2579
doi: 10.1245/s10434-014-3654-1
Konradsson M, van Berge Henegouwen MI, Bruns C, Chaudry MA, Cheong E, Cuesta MA, Darling GE, Gisbertz SS, Griffin SM, Gutschow CA, van Hillegersberg R, Hofstetter W, Hölscher AH, Kitagawa Y, van Lanschot JJB, Lindblad M, Ferri LE, Low DE, Luyer MDP, Ndegwa N, Mercer S, Moorthy K, Morse CR, Nafteux P, Nieuwehuijzen GAP, Pattyn P, Rosman C, Ruurda JP, Räsänen J, Schneider PM, Schröder W, Sgromo B, Van Veer H, Wijnhoven BPL, Nilsson M (2020) Diagnostic criteria and symptom grading for delayed gastric conduit emptying after esophagectomy for cancer: international expert consensus based on a modified Delphi process. Dis Esophagus 33
Antonoff MB, Puri V, Meyers BF, Baumgartner K, Bell JM, Broderick S, Krupnick AS, Kreisel D, Patterson GA, Crabtree TD (2014) Comparison of pyloric intervention strategies at the time of esophagectomy: is more better? Ann Thorac Surg 97:1950–1957 (discussion 1657–1958)
doi: 10.1016/j.athoracsur.2014.02.046
Urschel JD, Blewett CJ, Young JE, Miller JD, Bennett WF (2002) Pyloric drainage (pyloroplasty) or no drainage in gastric reconstruction after esophagectomy: a meta-analysis of randomized controlled trials. Dig Surg 19:160–164
doi: 10.1159/000064206
Arya S, Markar SR, Karthikesalingam A, Hanna GB (2015) The impact of pyloric drainage on clinical outcome following esophagectomy: a systematic review. Dis Esophagus 28:326–335
doi: 10.1111/dote.12191
Cerfolio RJ, Bryant AS, Canon CL, Dhawan R, Eloubeidi MA (2009) Is botulinum toxin injection of the pylorus during Ivor Lewis [corrected] esophagogastrectomy the optimal drainage strategy? J Thorac Cardiovasc Surg 137:565–572
doi: 10.1016/j.jtcvs.2008.08.049
Deng B, Tan QY, Jiang YG, Zhao YP, Zhou JH, Chen GC, Wang RW (2010) Prevention of early delayed gastric emptying after high-level esophagogastrostomy by “pyloric digital fracture.” World J Surg 34:2837–2843
doi: 10.1007/s00268-010-0766-z
Khashab MA, Stein E, Clarke JO, Saxena P, Kumbhari V, Chander Roland B, Kalloo AN, Stavropoulos S, Pasricha P, Inoue H (2013) Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc 78:764–768
doi: 10.1016/j.gie.2013.07.019
Jacques J, Pagnon L, Hure F, Legros R, Crepin S, Fauchais AL, Palat S, Ducrotté P, Marin B, Fontaine S, Boubaddi NE, Clement MP, Sautereau D, Loustaud-Ratti V, Gourcerol G, Monteil J (2019) Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function. Endoscopy 51:40–49
doi: 10.1055/a-0628-6639
Khashab MA, Ngamruengphong S, Carr-Locke D, Bapaye A, Benias PC, Serouya S, Dorwat S, Chaves DM, Artifon E, de Moura EG, Kumbhari V, Chavez YH, Bukhari M, Hajiyeva G, Ismail A, Chen YI, Chung H (2017) Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc 85:123–128
doi: 10.1016/j.gie.2016.06.048
Anderson MJ, Sippey M, Marks J (2020) Gastric per oral pyloromyotomy for post-vagotomy-induced gastroparesis following esophagectomy. J GastrointestSurg 24:715–719
doi: 10.1007/s11605-019-04418-3
Carroll PA, Yeung JC, Darling GE (2020) Elimination of routine feeding jejunostomy after esophagectomy. Ann Thorac Surg 110:1706–1713
doi: 10.1016/j.athoracsur.2020.04.072
Johansson J, Sloth M, Bajc M, Walther B (1999) Radioisotope evaluation of the esophageal remnant and the gastric conduit after gastric pull-up esophagectomy. Surgery 125:297–303
doi: 10.1016/S0039-6060(99)70240-0
Djerf P, Brundin M, Bajk M, Smedh U (2015) Validation of the paracetamol absorption test for measuring gastric tube emptying in esophagectomized patients versus gold standard scintigraphy. Scand J Gastroenterol 50:1339–1347
doi: 10.3109/00365521.2015.1041151

Auteurs

Yehonatan Nevo (Y)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, QC, Canada. yehonatan.nevo@mail.mcgill.ca.
Division of Thoracic Surgery, McGill University Health Centre, 1650 Cedar Avenue, Room L8-505, Montreal, QC, H3G 1A4, Canada. yehonatan.nevo@mail.mcgill.ca.

Alexander Calderone (A)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, QC, Canada.

Anitha Kammili (A)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, QC, Canada.

Cyril Boulila (C)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, QC, Canada.

Stephane Renaud (S)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, QC, Canada.
Department of Thoracic Surgery, Nancy Regional University Hospital, Nancy, France.

Jonathan Cools-Lartigue (J)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, QC, Canada.

Jonathan Spicer (J)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, QC, Canada.

Carmen Mueller (C)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, QC, Canada.

Lorenzo Ferri (L)

Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH